Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invekra
Mexico City, Lerma, Mexico City & State of Mexico, Mexico
- Ownership
- Private
- Employees
- ~6000
- Development stage
- Other
01
Overview
Invekra is the leading Mexican-controlled pharmaceutical conglomerate, holding over 185 brands and 371 SKUs in Mexico alone, with commercial products across Latin America. Its subsidiaries have established licensing and development programs with major global pharma partners. It acquired Latin American assets of Microdacyn® and built its own exclusive regional manufacturing and commercialization capabilities.
- Therapeutic areas
- CardiovascularPulmonologyInfectious DiseasesNeurologyGastroenterologyMetabolic DisordersWomen's HealthOtherDermatologyOncology
- Modalities
- Small moleculeBiologicVaccineAntibodyOTC productCombination product
- Industry
- Pharma
02
Partnerships
PfizerGSKBristol Myers SquibbServierTakedaMenariniDaiichi SankyoTanabeRecordatiViatris (Asta Medica)UriachBlistexLil Drug StorePint PharmaKinCoinnaught Laboratories (Sanyconn JV)
Beyond the preview
Go deeper on Invekra.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Invekra.